<p>Centene Corporation（纽约证券交易所代码：CNC - 获取免费报告）在周五市场开盘前出现了下跌。该股票此前收于 39.92 美元，但开盘时为 37.24 美元。Centene 的股票最后交易价格为 37.5860 美元，成交量为 1,700,182 股。</p>
<h2>Centene 重要新闻</h2>
<ul>
<li>MarketBeat 周回顾 – 07/07 - 07/11</li>
</ul>
<p>以下是本周影响 Centene 的主要新闻：</p>
<ul>
<li>积极情绪：Centene 发布了 2026 年调整后每股收益指引为 3.00 美元，高于市场共识的约 2.95 美元，管理层表示成本正在稳定——这表明盈利趋势可能在明年改善。路透社：Centene 预计 2026 年利润高于预期</li>
<li>中性情绪：Centene 强调了社区 outreach（与超级碗周相关的 Health Net 活动）——积极的公关，但不太可能影响近期基本面。PR Newswire：Health Net 和职业足球名人堂活动</li>
<li>中性情绪：立法进展（提议法案以扩大围绕怀孕的无成本共享心理健康福利）可能会随着时间的推移影响行业计划设计；对 Centene 的影响可能存在，但遥远且不确定。QuiverQuant：H.R.7227 摘要</li>
<li>消极情绪：尽管收入和每股收益损失预期超出预期，Centene 报告了第四季度的 GAAP 亏损（超过 10 亿美元；每股亏损 1.19 美元）——大幅转向 GAAP 亏损和持续高企的医疗成本使投资者对盈利波动和现金流的担忧加剧。福布斯：Centene 报告 10 亿美元亏损</li>
<li>消极情绪：关键盈利指标：合并健康福利比率（HBR）在第四季度为 94.3%（医疗补助 HBR 为 93.0%），表明医疗损失水平较高；Centene 的 2026 年收入指引（1865 亿美元–1905 亿美元）低于市场的约 1920 亿美元共识——收入指引未达预期 + 高 HBR 可能导致投资者失望。PR Newswire：Centene 2025 年业绩和 2026 年指引</li>
</ul>
<h2>华尔街分析师预测增长</h2>
<p>几位股票研究分析师对 CNC 股票发布了报告。Truist Financial 将 Centene 的目标价从 45.00 美元上调至 47.00 美元，并在 1 月 5 日的报告中给予该股票 “买入” 评级。TD Cowen 在 10 月 31 日的报告中重申了对 Centene 股票的 “持有” 评级。Jefferies Financial Group 在 11 月 3 日的研究报告中将 Centene 股票的目标价从 25.00 美元上调至 32.00 美元。Weiss Ratings 在 1 月 21 日的研究报告中重申了对 Centene 股票的 “卖出（d）” 评级。最后，摩根大通将 Centene 的目标价从 38.00 美元上调至 45.00 美元，并在 1 月 22 日的研究报告中给予该公司 “中性” 评级。三位研究分析师对该股票给予了 “买入” 评级，十二位给予了 “持有” 评级，三位给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，平均目标价为 40.81 美元。</p>
<ul>
<li>为什么 Centene 股票下跌了 40%——现在是否值得买入</li>
</ul>
<p><strong>查看我们最新的 Centene 股票报告</strong></p>
<h2>Centene 股票表现</h2>
<p>该公司的速动比率为 1.08，流动比率为 1.08，债务与股本比率为 0.83。该股票的 50 日移动平均线为 42.04 美元，200 日移动平均线为 35.81 美元。该公司的市值为 185.9 亿美元，市盈率为-3.49，市盈增长比率为 0.95，贝塔值为 0.48。</p>
<ul>
<li>顶级分析师评级的医疗保健股票值得关注</li>
</ul>
<p>Centene（纽约证券交易所代码：CNC - 获取免费报告）最近在 2 月 6 日宣布了季度财报。该公司报告季度每股收益为（1.19 美元），超出分析师共识预期的（1.25 美元）0.06 美元。该公司在本季度的收入为 497.3 亿美元，而共识预期为 484.1 亿美元。Centene 的净利润率为-2.85%，股本回报率为 7.82%。该公司的季度收入同比增长 21.9%。去年同期，该公司每股收益为 0.80 美元。Centene 已将其 2026 财年的指引设定为 3.000-3.000 每股收益。分析师平均预测 Centene Corporation 在当前年度的每股收益为 6.86 美元。</p>
<h2>机构资金流入和流出</h2>
<p>对冲基金和其他机构投资者最近对该公司的持仓进行了调整。Addison Advisors LLC 在第三季度将其在 Centene 的持股增加了 455.6%。Addison Advisors LLC 现在拥有 739 股该公司的股票，价值 26,000 美元，在此期间又增持了 606 股。SBI Securities Co. Ltd.在第四季度将其在 Centene 的持股增加了 118.4%。SBI Securities Co. Ltd.现在拥有 749 股该公司的股票，价值 31,000 美元，在此期间又增持了 406 股。Mowery &amp; Schoenfeld Wealth Management LLC 在第三季度收购了 Centene 的新股份，价值约 27,000 美元。GoalVest Advisory LLC 在第四季度收购了 Centene 的新股份，价值约 37,000 美元。最后，Union Bancaire Privee UBP SA 在第四季度收购了 Centene 的新股份，价值约 37,000 美元。目前 93.63% 的股票由机构投资者持有。</p>
<h2>关于 Centene</h2>
<p>（获取免费报告）</p>
<p>Centene Corporation（纽约证券交易所代码：CNC）是一家多元化的跨国医疗企业，专注于为政府资助和国家健康计划提供服务。该公司主要作为一家管理医疗保健组织，提供医疗保险并管理医疗补助、儿童健康保险计划（CHIP）、医疗保险优势计划和个人市场计划的福利。Centene 还与联邦和州机构签订合同，管理特殊护理计划和为弱势群体提供社区服务。</p>
<p>Centene 的产品不仅限于传统保险，还包括一系列专业和支持服务。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票超过 Centene</li>
<li>你的银行账户不再安全</li>
<li>特朗普策划了国税局的死亡 ☠️</li>
<li>用这四个简单步骤 “防止美联储影响” 你的银行账户</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>华尔街的新体育预测交易</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Centene 吗？</h2>
<p>在你考虑 Centene 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前...而 Centene 并不在名单上。</p>
<p>虽然 Centene 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

康西哥

<p>Centene Corporation（纽约证券交易所代码：CNC）股价从 39.92 美元跳空下跌至 37.24 美元，随后交易于 37.5860 美元。该公司发布了 2026 年调整后每股收益（EPS）指引为 3.00 美元，高于市场共识的 2.95 美元，显示出潜在的盈利改善。然而，它报告了第四季度超过 10 亿美元的 GAAP 亏损，引发了投资者的担忧。分析师的评级意见不一，市场共识评级为 “持有”，平均目标价为 40.81 美元。机构投资者增加了持股比例，反映出尽管近期股市波动，仍然对该公司保持持续关注</p>

<p>Centene Corporation (NYSE:CNC - Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $39.92, but opened at $37.24. Centene shares last traded at $37.5860, with a volume of 1,700,182 shares changing hands.</p>
<div class="lb-trans"><p>Centene Corporation（纽约证券交易所代码：CNC - 获取免费报告）在周五市场开盘前出现了下跌。该股票此前收于 39.92 美元，但开盘时为 37.24 美元。Centene 的股票最后交易价格为 37.5860 美元，成交量为 1,700,182 股。</p>
</div><h2>Key Centene News</h2>
<div class="lb-trans"><h2>Centene 重要新闻</h2>
</div><ul>
<li>MarketBeat Week in Review – 07/07 - 07/11</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 07/07 - 07/11</li>
</ul>
</div><p>Here are the key news stories impacting Centene this week:</p>
<div class="lb-trans"><p>以下是本周影响 Centene 的主要新闻：</p>
</div><ul>
<li>Positive Sentiment: Centene issued 2026 adjusted EPS guidance at $3.00, above the consensus ~ $2.95, and management said costs are stabilizing — a signal that profitability trends could improve next year. Reuters: Centene sees 2026 profit above estimates</li>
<li>Neutral Sentiment: Centene highlighted community outreach (Health Net events tied to Super Bowl week) — positive PR but unlikely to move near-term fundamentals. PR Newswire: Health Net and Pro Football Hall of Fame events</li>
<li>Neutral Sentiment: Legislative developments (a proposed bill to expand no-cost-sharing mental-health benefits around pregnancy) could affect industry plan design over time; impact on Centene is possible but distant and uncertain. QuiverQuant: H.R.7227 summary</li>
<li>Negative Sentiment: Centene reported a fourth-quarter GAAP loss (more than $1B; $(1.19) EPS) despite beating revenue and the consensus EPS loss estimate — the swing to a large GAAP loss and continued elevated medical costs keep investor concern about earnings volatility and cash flow. Forbes: Centene reports $1 billion loss</li>
<li>Negative Sentiment: Key profitability metric: consolidated Health Benefit Ratio (HBR) was 94.3% in Q4 (Medicaid HBR 93.0%), indicating high medical-loss levels; and Centene’s 2026 revenue guidance ($186.5B–$190.5B) is below the Street’s ~$192B consensus — revenue guidance miss + high HBRs likely drove investor disappointment. PR Newswire: Centene 2025 results and 2026 guidance</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：Centene 发布了 2026 年调整后每股收益指引为 3.00 美元，高于市场共识的约 2.95 美元，管理层表示成本正在稳定——这表明盈利趋势可能在明年改善。路透社：Centene 预计 2026 年利润高于预期</li>
<li>中性情绪：Centene 强调了社区 outreach（与超级碗周相关的 Health Net 活动）——积极的公关，但不太可能影响近期基本面。PR Newswire：Health Net 和职业足球名人堂活动</li>
<li>中性情绪：立法进展（提议法案以扩大围绕怀孕的无成本共享心理健康福利）可能会随着时间的推移影响行业计划设计；对 Centene 的影响可能存在，但遥远且不确定。QuiverQuant：H.R.7227 摘要</li>
<li>消极情绪：尽管收入和每股收益损失预期超出预期，Centene 报告了第四季度的 GAAP 亏损（超过 10 亿美元；每股亏损 1.19 美元）——大幅转向 GAAP 亏损和持续高企的医疗成本使投资者对盈利波动和现金流的担忧加剧。福布斯：Centene 报告 10 亿美元亏损</li>
<li>消极情绪：关键盈利指标：合并健康福利比率（HBR）在第四季度为 94.3%（医疗补助 HBR 为 93.0%），表明医疗损失水平较高；Centene 的 2026 年收入指引（1865 亿美元–1905 亿美元）低于市场的约 1920 亿美元共识——收入指引未达预期 + 高 HBR 可能导致投资者失望。PR Newswire：Centene 2025 年业绩和 2026 年指引</li>
</ul>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several equities research analysts have issued reports on CNC shares. Truist Financial increased their price target on Centene from $45.00 to $47.00 and gave the stock a &#34;buy&#34; rating in a report on Monday, January 5th. TD Cowen restated a &#34;hold&#34; rating on shares of Centene in a report on Friday, October 31st. Jefferies Financial Group increased their price objective on shares of Centene from $25.00 to $32.00 in a research report on Monday, November 3rd. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of Centene in a research report on Wednesday, January 21st. Finally, JPMorgan Chase &amp; Co. lifted their price target on Centene from $38.00 to $45.00 and gave the company a &#34;neutral&#34; rating in a research note on Thursday, January 22nd. Three research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Hold&#34; and an average target price of $40.81.</p>
<div class="lb-trans"><p>几位股票研究分析师对 CNC 股票发布了报告。Truist Financial 将 Centene 的目标价从 45.00 美元上调至 47.00 美元，并在 1 月 5 日的报告中给予该股票 “买入” 评级。TD Cowen 在 10 月 31 日的报告中重申了对 Centene 股票的 “持有” 评级。Jefferies Financial Group 在 11 月 3 日的研究报告中将 Centene 股票的目标价从 25.00 美元上调至 32.00 美元。Weiss Ratings 在 1 月 21 日的研究报告中重申了对 Centene 股票的 “卖出（d）” 评级。最后，摩根大通将 Centene 的目标价从 38.00 美元上调至 45.00 美元，并在 1 月 22 日的研究报告中给予该公司 “中性” 评级。三位研究分析师对该股票给予了 “买入” 评级，十二位给予了 “持有” 评级，三位给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，平均目标价为 40.81 美元。</p>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 Centene 股票下跌了 40%——现在是否值得买入</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Report on Centene</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Centene 股票报告</strong></p>
</div><h2>Centene Stock Performance</h2>
<div class="lb-trans"><h2>Centene 股票表现</h2>
</div><p>The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.83. The stock's fifty day moving average is $42.04 and its two-hundred day moving average is $35.81. The firm has a market capitalization of $18.59 billion, a price-to-earnings ratio of -3.49, a P/E/G ratio of 0.95 and a beta of 0.48.</p>
<div class="lb-trans"><p>该公司的速动比率为 1.08，流动比率为 1.08，债务与股本比率为 0.83。该股票的 50 日移动平均线为 42.04 美元，200 日移动平均线为 35.81 美元。该公司的市值为 185.9 亿美元，市盈率为-3.49，市盈增长比率为 0.95，贝塔值为 0.48。</p>
</div><ul>
<li>Top Analyst-Rated Healthcare Stocks to Watch Now</li>
</ul>
<div class="lb-trans"><ul>
<li>顶级分析师评级的医疗保健股票值得关注</li>
</ul>
</div><p>Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, beating analysts' consensus estimates of ($1.25) by $0.06. The company had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The company's quarterly revenue was up 21.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, analysts predict that Centene Corporation will post 6.86 earnings per share for the current year.</p>
<div class="lb-trans"><p>Centene（纽约证券交易所代码：CNC - 获取免费报告）最近在 2 月 6 日宣布了季度财报。该公司报告季度每股收益为（1.19 美元），超出分析师共识预期的（1.25 美元）0.06 美元。该公司在本季度的收入为 497.3 亿美元，而共识预期为 484.1 亿美元。Centene 的净利润率为-2.85%，股本回报率为 7.82%。该公司的季度收入同比增长 21.9%。去年同期，该公司每股收益为 0.80 美元。Centene 已将其 2026 财年的指引设定为 3.000-3.000 每股收益。分析师平均预测 Centene Corporation 在当前年度的每股收益为 6.86 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the business. Addison Advisors LLC raised its stake in Centene by 455.6% in the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company's stock valued at $26,000 after acquiring an additional 606 shares during the period. SBI Securities Co. Ltd. raised its position in shares of Centene by 118.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company's stock valued at $31,000 after purchasing an additional 406 shares during the period. Mowery &amp; Schoenfeld Wealth Management LLC acquired a new stake in shares of Centene during the 3rd quarter worth about $27,000. GoalVest Advisory LLC bought a new stake in shares of Centene during the 4th quarter worth about $37,000. Finally, Union Bancaire Privee UBP SA acquired a new position in Centene in the 4th quarter valued at about $37,000. 93.63% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近对该公司的持仓进行了调整。Addison Advisors LLC 在第三季度将其在 Centene 的持股增加了 455.6%。Addison Advisors LLC 现在拥有 739 股该公司的股票，价值 26,000 美元，在此期间又增持了 606 股。SBI Securities Co. Ltd.在第四季度将其在 Centene 的持股增加了 118.4%。SBI Securities Co. Ltd.现在拥有 749 股该公司的股票，价值 31,000 美元，在此期间又增持了 406 股。Mowery &amp; Schoenfeld Wealth Management LLC 在第三季度收购了 Centene 的新股份，价值约 27,000 美元。GoalVest Advisory LLC 在第四季度收购了 Centene 的新股份，价值约 37,000 美元。最后，Union Bancaire Privee UBP SA 在第四季度收购了 Centene 的新股份，价值约 37,000 美元。目前 93.63% 的股票由机构投资者持有。</p>
</div><h2>About Centene</h2>
<div class="lb-trans"><h2>关于 Centene</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Centene Corporation NYSE: CNC is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children's Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.</p>
<div class="lb-trans"><p>Centene Corporation（纽约证券交易所代码：CNC）是一家多元化的跨国医疗企业，专注于为政府资助和国家健康计划提供服务。该公司主要作为一家管理医疗保健组织，提供医疗保险并管理医疗补助、儿童健康保险计划（CHIP）、医疗保险优势计划和个人市场计划的福利。Centene 还与联邦和州机构签订合同，管理特殊护理计划和为弱势群体提供社区服务。</p>
</div><p>Centene's offerings extend beyond traditional insurance to include a range of specialty and support services.</p>
<div class="lb-trans"><p>Centene 的产品不仅限于传统保险，还包括一系列专业和支持服务。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Centene</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Trump Devises the Death of the IRS ☠️</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>Wall Street’s New Sports Prediction Trade</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Centene</li>
<li>你的银行账户不再安全</li>
<li>特朗普策划了国税局的死亡 ☠️</li>
<li>用这四个简单步骤 “防止美联储影响” 你的银行账户</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>华尔街的新体育预测交易</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Centene Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Centene 吗？</h2>
</div><p>Before you consider Centene, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Centene 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前...而 Centene 并不在名单上。</p>
</div><p>While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Centene 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Centene (NYSE:CNC) 股价跳空下跌 - 以下是发生的情况